Download Files:
SSR411298
SKU
HY-123863-10 mg
Category Reference compound
Tags FAAH, Metabolic Enzyme/Protease;Neuronal Signaling, Neurological Disease; Cancer
$510 – $4,200
Products Details
Product Description
– SSR411298 is an orally active, selective and reversible fatty acid amide hydrolase (FAAH) inhibitor. SSR411298 has the potential for post-traumatic stress disorder research[1].
Web ID
– HY-123863
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C21H26N2O6
References
– [1]Guy Griebel, et al. The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents. Sci Rep. 2018 Feb 5;8(1):2416.
CAS Number
– 666860-59-9
Molecular Weight
– 402.44
Compound Purity
– 99.75
SMILES
– COC1=CC2=C(C=C1)C([C@@H]3CO[C@H](OC3)CCCNC(OCC(N)=O)=O)=CC=C2
Clinical Information
– Phase 2
Research Area
– Neurological Disease; Cancer
Solubility
– DMSO : 100 mg/mL (ultrasonic)
Target
– FAAH
Pathway
– Metabolic Enzyme/Protease;Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.